🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

So the time has arrived... Advanced Chemotherapy Technologies is now Focal Medical. Along with that name change comes an expanded team, a growing technology platform, and new applications in oncology and gene therapy. businesswire.com/news/home/2022…

Check out this job from Focal Medical, Inc. linkedin.com/jobs/view/3371…

Focal Medical, Inc. is sponsoring a study with Virginia Tech’s Animal Cancer Care and Research Center to treat oral cancer in dogs. Recruitment is now open! research.vetmed.vt.edu/clinical-trial…

On #InternationalWomensDay2023, we celebrate the work of our incredible team of women scientists who constitute the core of our Scientific research team. Read more here: linkedin.com/posts/focal-me…

So proud of Joe Kearney, surgical resident extraordinaire in the Yeh Lab for delivering an excellent plenary talk at #AHPBA23. Interesting data on the differences between classical and basal subtypes in response to current neoadjuvant therapy. UNC Pancreas Center UNC Surgery

Let’s work to find better treatments for patients w basal tumors #PancreaticCancer ‼️‼️‼️ Neo FOLFIRINOX not working. Susan Tsai, MD, MHS MCW LaBahn Pancreatic Cancer Program clinicaltrials.gov/ct2/show/NCT04… 🎉🎉🎉Joe Kearney UNC Surgery UNC iTOP (integrated Translational Onc Program) @unclineberger #AHPBA2023 presidential plenary 🙌🙌🙌

Thank you, Mindy, Ilektra, and the entire Virginia-Maryland College of Veterinary Medicine team for working closely with Focal Medical, Inc. to ensure that human and animal healthcare can advance hand in hand. fb.watch/jsSXulrIsv/

We've partnered with Virginia-Maryland College of Veterinary Medicine to use our technology in this new and exciting study. If your canine friend is eligible, please have your veterinarian submit a referral today! linkedin.com/feed/update/ur…

We're proud to be partnering with the Virginia Tech Animal Cancer Care & Research Center on this study! Learn more about how we are exploring the use of iontophoresis to deliver targeted chemotherapies to treat oral cancer in canines in the link below. focalmedical.co/2023/05/initia…

Great news! Just learned that UNC Lineberger Surgeon-scientist Jen Jen Yeh Yeh Lab was recently appointed to the PanCAN SMAB. Congratulations and best wishes helping to identify and accelerate new and innovative therapies to the patients that desperately need them.

We recognize November 16, 2023 as World Pancreatic Cancer Day. Focal is proud to unite in the fight against one of the world’s deadliest cancers. To learn more about our efforts to improve the lives of patients diagnosed with pancreatic cancer, visit focalmedical.co

On this final day of #pancreaticcancerawarenessmonth we are proud to unite in the fight against one of the deadliest cancers. Innovate Carolina recently published this article focused on our origin, our future, & what we've learned so far. Check it out here: innovate.unc.edu/the-prognosis-…

Exciting News! Focal Medical has received FDA clearance of an IND application to initiate a Phase 1b clinical trial of the Company’s first targeted therapeutic product, ACT-IOP-003. For more information, read the full news release here: businesswire.com/news/home/2024…

#PancreaticAdenocarcinoma is an especially challenging disease to treat. In our lead program, we target locally advanced nonresectable pancreatic cancer and shift the paradigm in how therapy is delivered. To learn more, visit: focalmedical.co/applications/

We are pleased to announce that Ness Bermingham, Ph.D., operating partner at Khosla Ventures and founder of Intellia Therapeutics, has joined our Board of Directors! For more, visit: focalmedical.co/2024/01/focal-…

Focal Medical announces receipt of award from National Cancer Institute to develop treatment for oral cavity cancer. More here: focalmedical.co/2024/03/focal-…

Focal Medical is now Continuity Biosciences! prnewswire.co.uk/news-releases/…